Gainers & Losers
Fri Apr 17 2026 10:29:59- Hindustan Unilever share price
- ₹2,241.104.75%
- Power Grid Corporation of ...
- ₹318.051.86%
- Reliance Industries share price
- ₹1,365.101.61%
- Bharat Electronics share price
- ₹462.701.56%
- Tech Mahindra share price
- ₹1,511.851.41%
Active Stocks
Fri Apr 17 2026 10:29:21- Suzlon Energy share price
- ₹52.945.33%
- Yes Bank share price
- ₹20.201.25%
- Adani Power share price
- ₹198.402.74%
- Wipro share price
- ₹204.35-2.78%
- Jio Financial Services share price
- ₹243.951.10%
Home/Market/Market Stats/Sotac Pharmaceuticals share price/ Sotac Pharmaceuticals Profit Loss Annual
Sotac Pharmaceuticals Profit & Loss Annual
117.00 +5.00 (4.46%)Updated : 17 Apr 2026
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 87.17 | 98.65 | 51.40 | 68.14 |
| Other Net | 2.96 | 0.31 | 0.15 | 0.18 |
| Diluted Weighted Average Shares | 1.11 | 1.11 | 1.11 | 1.11 |
| Depreciation/ Amortization | 3.84 | 3.10 | 1.63 | 1.13 |
| Operating Income | 9.81 | 5.18 | 6.58 | 5.01 |
| Net Income | 8.03 | 3.58 | 4.50 | 2.88 |
| Income Availableto Com Excl Extra Ord | 8.03 | 3.58 | 4.50 | 2.88 |
| Other Operating Expenses Total | 0.11 | 11.94 | 6.78 | - |
| Net Income Before Taxes | 11.12 | 3.96 | 5.96 | 4.69 |
| Minority Interest | -1.25 | - | - | - |
| Net Income After Taxes | 9.28 | 3.58 | 4.50 | 2.88 |
| Income Availableto Com Incl Extra Ord | 8.03 | 3.58 | 4.50 | 2.88 |
| Costof Revenue Total | 68.31 | 79.61 | 40.07 | 55.98 |
| Gross Profit | 28.68 | 24.22 | 17.92 | 17.17 |
| Interest Inc( Exp) Net- Non- Op Total | -1.66 | -1.52 | -0.76 | -0.49 |
| Diluted Net Income | 8.03 | 3.58 | 4.50 | 2.88 |
| DPS- Common Stock Primary Issue | 0.10 | - | - | - |
| Provisionfor Income Taxes | 1.84 | 0.38 | 1.47 | 1.82 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 8.03 | 3.58 | 4.50 | 2.88 |
| Total Revenue | 96.99 | 103.83 | 57.98 | 73.15 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 96.99 | 103.83 | 57.98 | 73.15 |
| Selling/ General/ Admin Expenses Total | 14.92 | 4.00 | 2.93 | 9.20 |
| Diluted Normalized EPS | 7.26 | 3.24 | 4.07 | 3.62 |
| Diluted EPS Excluding Extra Ord Items | 7.26 | 3.24 | 4.07 | 2.61 |
| Unusual Expense( Income) | - | - | - | 1.84 |
*All figures in crores except per share values
Sotac Pharmaceuticals Quick Links
Sotac Pharmaceuticals Dividend Sotac Pharmaceuticals Bonus Sotac Pharmaceuticals News Sotac Pharmaceuticals AGM Sotac Pharmaceuticals Rights Sotac Pharmaceuticals Splits Sotac Pharmaceuticals Board Meetings Sotac Pharmaceuticals Key Metrics Sotac Pharmaceuticals Shareholdings Sotac Pharmaceuticals Balance Sheet Sotac Pharmaceuticals Cashflow Sotac Pharmaceuticals Q1 Results Sotac Pharmaceuticals Q2 Results Sotac Pharmaceuticals Q3 Results Sotac Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
359.35+14.15(4.10%)
245.05+8.85(3.75%)
4,077.55+123.65(3.13%)
1,340.70-9.85 (-0.73%)
1,868.00-2.40 (-0.13%)